12,372 trials
Atherosclerosis · Percutaneous Coronary Intervention · Acute Coronary Syndrome
Primary: The Composite Incidence of All-cause Mortality, Myocardial Infarction (MI), Ischemia-driven Revascularization (IDR) and Stent Thrombosis (ST) — 257; 322 participants
Respiratory Syncytial Virus Infection
Primary: Serum Palivizumab Trough Concentrations at Day 1, Day 31, and Day 121 — 0; 59.0; 91.8 µg/mL
Carcinoma, Renal Cell
Primary: Progression-free Survival (PFS) — 8.4; 9.5 Months
Influenza
Primary: Titers for Hemagglutination Inhibition (HI) Antibodies Against 4 Strains of Influenza Disease — 14.7; 15.6; 14.4; 201.1 Titer
Schizophrenia
Primary: Change From Baseline in the Positive and Negative Syndrome Scale (PANSS) Total Score at Week 13 or Early Discontinuation — 83.5; 85.7; 6.9; -3.1 units on a scale…
Myelogenous Leukemia, Chronic
Primary: Major Molecular Response Rate (MMR) at 12 Months Between All 3 Arms - With Imputation — 22.3; 44.3; 42.7 Percentage of participants — p=<0.0001
Pregnancy Prevention
Primary: All Users Pregnancy Rates Based on Pearl Index (PI) Analyses for 91-Day Cycles and Broken Out by Subpopulations Defined by Participant Weight — 2.82; 2.46; 4.54…
Breast Cancer
Primary: Progression Free Survival (PFS) — 4.8; 2.4; 5.8; 2.9 Months
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Change in Short Physical Performance Battery (SPPB) Score — 0.6; 0.9 units on a scale — p=0.55
Pulmonary Hypertension
Primary: Six Minute Walk Distance (6MWD) — 362.5; 362.5; 367.0; 381.0 meters — p=0.072
HIV Infections · Pneumococcal Infections
Primary: Geometric Mean Fold Rise (GMFR) for Serotype-specific Pneumococcal Immunoglobulin G (IgG) Antibody From 1 Month After Dose 2 of 13vPnC to 1 Month After Dose 3 of 13vPnC…
Dental Caries
Primary: Natural Log Transformed Area Under the Fluoride Concentration in Plaque Fluid by Time Curve (AUC) Between 0-4 Hours — 0.54; 0.54 ln(μg*F*minutes/cm^2) — p=0.9762
Liver Disease, Alcoholic
Primary: Changes in Serum AST Levels — -13.5; -56 Units per liter (U/L)
Patient Computer Dialog
Primary: Patient Post Medical History Assessment Questionnaire — 8.4; 8.3 units on a scale
ADHD · Substance Abuse
Primary: ADHD Severity — -20.6; -21.8 units on a scale